The role of neuroimaging in neurotoxicity after chimeric antigen receptor T-cell therapy
Therapeutic Advances in Neurological Disorders
Published online on January 12, 2026
Abstract
Therapeutic Advances in Neurological Disorders, Volume 19, January-December 2026.
Chimeric antigen receptor T-cell (CAR-T) therapy has become an established treatment for several haematological malignancies in relapse and is being evaluated for new indications. An important clinical challenge associated with the use of CAR-T therapy, ...
Chimeric antigen receptor T-cell (CAR-T) therapy has become an established treatment for several haematological malignancies in relapse and is being evaluated for new indications. An important clinical challenge associated with the use of CAR-T therapy, ...